Kyung Hee Lee is a notable inventor based in Anyang, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of metabolic bone diseases. With a total of 2 patents, his work showcases innovative approaches to improving patient outcomes.

Latest Patents

Kyung Hee Lee's latest patents include a pharmaceutical composition for the treatment of metabolic bone disease. This invention focuses on a composite pharmaceutical agent that combines calcitriol and alendronate, which work synergistically to reduce spine fractures and increase bone density. The composition also addresses issues such as hypercalcemia and improves drug compliance, effectively preventing osteoporosis. Another significant patent involves a pharmaceutical composition comprising ticlopidine and Ginkgo biloba extract. This anti-thrombotic preparation utilizes the combined effects of these two components to mitigate the side effects associated with ticlopidine, such as neutropenia and agranulocytosis.

Career Highlights

Throughout his career, Kyung Hee Lee has worked with various companies, including Yuyu Industrial Co., Ltd. and Yuyu International Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Kyung Hee Lee has collaborated with notable colleagues, including Sung An Kang and Yong Oh Lee. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Kyung Hee Lee's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical treatments. His innovative patents reflect a deep understanding of the complexities involved in treating metabolic bone diseases and improving patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com